2024 Q4 Form 10-Q Financial Statement

#000143774924034901 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $13.21M $10.89M
YoY Change 21.36% 29.36%
Cost Of Revenue $6.230M
YoY Change
Gross Profit $4.658M
YoY Change
Gross Profit Margin 42.78%
Selling, General & Admin $2.625M
YoY Change
% of Gross Profit 56.35%
Research & Development $714.0K $566.0K
YoY Change 26.15%
% of Gross Profit 12.15%
Depreciation & Amortization $205.0K
YoY Change 10.22%
% of Gross Profit 4.4%
Operating Expenses $714.0K $2.625M
YoY Change -72.8% -66.29%
Operating Profit $2.921M $2.033M
YoY Change 43.68% 222.7%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $87.00K $13.00K
YoY Change 569.23% -181.25%
Pretax Income $3.008M $2.046M
YoY Change 47.02% 233.22%
Income Tax $741.0K $460.0K
% Of Pretax Income 24.63% 22.48%
Net Earnings $2.267M $1.586M
YoY Change 42.94% 215.31%
Net Earnings / Revenue 17.16% 14.57%
Basic Earnings Per Share $0.82 $0.59
Diluted Earnings Per Share $0.81 $0.57
COMMON SHARES
Basic Shares Outstanding 2.866M 2.809M 2.727M
Diluted Shares Outstanding 2.801M 2.760M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.552M
YoY Change 216.63%
Cash & Equivalents $8.490M $2.552M
Short-Term Investments
Other Short-Term Assets $419.0K
YoY Change 195.07%
Inventory $9.553M $8.962M
Prepaid Expenses
Receivables $6.058M $5.031M
Other Receivables $0.00
Total Short-Term Assets $24.66M $16.96M
YoY Change 45.34% 24.9%
LONG-TERM ASSETS
Property, Plant & Equipment $4.887M $3.635M
YoY Change 34.44% 2.14%
Goodwill $40.00K
YoY Change
Intangibles $40.00K $58.00K
YoY Change -31.03%
Long-Term Investments
YoY Change
Other Assets $7.000K $12.00K
YoY Change -41.67% -33.33%
Total Long-Term Assets $6.860M $4.821M
YoY Change 42.29% -52.73%
TOTAL ASSETS
Total Short-Term Assets $24.66M $16.96M
Total Long-Term Assets $6.860M $4.821M
Total Assets $31.52M $21.79M
YoY Change 44.67% -8.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.225M $1.418M
YoY Change -13.61% -52.34%
Accrued Expenses $2.471M
YoY Change 47.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.287M $3.992M
YoY Change 32.44% -15.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $40.00K
YoY Change -56.04%
Total Long-Term Liabilities $40.00K
YoY Change -56.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.287M $3.992M
Total Long-Term Liabilities $40.00K
Total Liabilities $5.296M $4.032M
YoY Change 31.35% -16.3%
SHAREHOLDERS EQUITY
Retained Earnings $9.198M $3.628M
YoY Change 153.53%
Common Stock $17.02M $14.13M
YoY Change 20.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.22M $17.75M
YoY Change
Total Liabilities & Shareholders Equity $31.52M $21.79M
YoY Change 44.67% -8.39%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $2.267M $1.586M
YoY Change 42.94% 215.31%
Depreciation, Depletion And Amortization $205.0K
YoY Change 10.22%
Cash From Operating Activities $1.494M
YoY Change 519.92%
INVESTING ACTIVITIES
Capital Expenditures $263.0K
YoY Change -198.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$263.0K
YoY Change -1.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 1.494M
Cash From Investing Activities -263.0K
Cash From Financing Activities 0.000
Net Change In Cash 1.231M
YoY Change -514.48%
FREE CASH FLOW
Cash From Operating Activities $1.494M
Capital Expenditures $263.0K
Free Cash Flow $1.231M
YoY Change 141.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
M-tron Industries, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001902314
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
168000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
141000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2814579
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2814579
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2786321
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2786321
mpti Investment Expense Rate
InvestmentExpenseRate
0.0008 pure
CY2023Q3 us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
CY2024Q3 us-gaap Assets Under Management Carrying Amount
AssetsUnderManagementCarryingAmount
0 usd
CY2022Q2 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41391
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0457944
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 Shader Rd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32804
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
298-2000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
dei Trading Symbol
TradingSymbol
MPTI
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2865849
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13214000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10888000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36207000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30395000 usd
CY2024Q3 us-gaap Manufacturing Costs
ManufacturingCosts
6904000 usd
CY2023Q3 us-gaap Manufacturing Costs
ManufacturingCosts
6230000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
19617000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
18322000 usd
CY2024Q3 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
3389000 usd
CY2023Q3 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
2625000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
9773000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
7714000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
10293000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
8855000 usd
us-gaap Costs And Expenses
CostsAndExpenses
29390000 usd
us-gaap Costs And Expenses
CostsAndExpenses
26036000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2921000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2033000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6817000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4359000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
63000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
139000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
87000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
200000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3008000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2046000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7017000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4347000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
741000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
460000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1520000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
931000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2267000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1586000 usd
us-gaap Net Income Loss
NetIncomeLoss
5497000 usd
us-gaap Net Income Loss
NetIncomeLoss
3416000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2751924
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2703840
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2729803
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2693400
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2800820
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2759780
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2788046
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2739819
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8490000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3913000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6058000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4802000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
9553000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
8884000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
555000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
588000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
24656000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18187000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4887000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4131000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
45000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1894000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1835000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000 usd
CY2024Q3 us-gaap Assets
Assets
31516000 usd
CY2023Q4 us-gaap Assets
Assets
24305000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1225000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1300000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2785000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2196000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
759000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
611000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
518000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
277000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5287000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4384000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5296000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4410000 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16995000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16167000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9198000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3701000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
26220000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19895000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31516000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24305000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23660000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2267000 usd
CY2024Q3 mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
216000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
26220000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16081000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1586000 usd
CY2023Q3 mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
17753000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19895000 usd
us-gaap Net Income Loss
NetIncomeLoss
5497000 usd
mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
485000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
343000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
26220000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14341000 usd
us-gaap Net Income Loss
NetIncomeLoss
3416000 usd
mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
-219000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
297000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
17753000 usd
us-gaap Net Income Loss
NetIncomeLoss
5497000 usd
us-gaap Net Income Loss
NetIncomeLoss
3416000 usd
us-gaap Depreciation
Depreciation
717000 usd
us-gaap Depreciation
Depreciation
577000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
485000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
297000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-59000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
41000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1256000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-166000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
669000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1444000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-36000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-258000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
951000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1078000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
210000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1143000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5707000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2273000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1473000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
565000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1473000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-565000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
343000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
343000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4577000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1626000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3913000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
926000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8490000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2552000 usd
us-gaap Interest Paid Net
InterestPaidNet
7000 usd
us-gaap Interest Paid Net
InterestPaidNet
14000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1296000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1032000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
714000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2029000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
566000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1630000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Concentration Risks</i></b></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For the three months ended September 30, 2024, the Company's largest and second largest customers accounted for $4,481, or 33.9%, and $2,582, or 19.5%, of the Company's Revenues, respectively. For the three months ended September 30, 2023, the Company's largest and second largest customers accounted for $3,738, or 34.3%, and $2,796, or 25.7%, of the Company’s Revenues, respectively.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For the nine months ended September 30, 2024, the Company's largest and second largest customers accounted for $13,808, or 38.1%, and $7,001, or 19.3%, of the Company's Revenues, respectively. For the nine months ended September 30, 2023, the Company's largest and second largest customers accounted for $8,795, or 28.9%, and $5,467, or 18.0%, of the Company's Revenues, respectively.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of September 30, 2024, the Company's <span style="-sec-ix-hidden:c120797343">four</span> largest customers accounted for approximately $4,268, or 68.6%, of gross accounts receivable. As of December 31, 2023, <span style="-sec-ix-hidden:c120797346">four</span> of the Company's largest customers accounted for approximately $3,774, or 76.4%, of gross accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit. As a result, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2024Q3 mpti Investment Expense Rate
InvestmentExpenseRate
0.0008 pure
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.225 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2267000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1586000 usd
us-gaap Net Income Loss
NetIncomeLoss
5497000 usd
us-gaap Net Income Loss
NetIncomeLoss
3416000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2751924
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2703840
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2729803
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2693400
CY2024Q3 mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2023Q3 mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
9710
mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
71
mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
9710
CY2024Q3 mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
48896
CY2023Q3 mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
46230
mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
58172
mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
36709
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2800820
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2759780
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2788046
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2739819
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4574000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4368000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4737000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4150000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1701000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1634000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
11012000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
10152000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1459000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1268000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
9553000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
8884000 usd
CY2024Q3 us-gaap Land
Land
536000 usd
CY2023Q4 us-gaap Land
Land
536000 usd
CY2024Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5321000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5216000 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21414000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
20046000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27271000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25798000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22384000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21667000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4887000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4131000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
40000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
40000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1266000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1266000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1226000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1221000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45000 usd

Files In Submission

Name View Source Status
0001437749-24-034901-index-headers.html Edgar Link pending
0001437749-24-034901-index.html Edgar Link pending
0001437749-24-034901.txt Edgar Link pending
0001437749-24-034901-xbrl.zip Edgar Link pending
ex_714757.htm Edgar Link pending
ex_714758.htm Edgar Link pending
ex_714759.htm Edgar Link pending
ex_714760.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpti-20240930.xsd Edgar Link pending
mpti20240930_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpti-20240930_cal.xml Edgar Link unprocessable
mpti-20240930_def.xml Edgar Link unprocessable
mpti-20240930_lab.xml Edgar Link unprocessable
mpti-20240930_pre.xml Edgar Link unprocessable
mpti20240930_10q_htm.xml Edgar Link completed
mtronlogosmall.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending